Revolutionizing ECG interpretation with AI-powered universal smartphone technology
Overview
This Powerful Medical abstract describes PMcardio, a smartphone application that uses image recognition and artificial intelligence (AI) to standardize and digitize photographs of 12-lead ECGs. Once an ECG is digitized, the app interprets 38 different cardiovascular diseases and provides guideline-compliant recommendations for patient referral and further diagnostic and treatment options. The authors present it as a response to a common gap: millions of ECGs are recorded every year, often without an expert cardiologist available to interpret them, and simple computerized interpretation algorithms built into ECG devices often give inadequate interpretations. The abstract is a technology description and does not report accuracy or outcome data.
Key findings
- The PMcardio smartphone app uses image recognition and AI to turn a photograph of a 12-lead ECG into a standardized digital recording.
- From the digitized 12-lead ECG, the app interprets 38 different cardiovascular diseases and provides guideline-compliant recommendations for referral, diagnostics and treatment.
- The abstract names 4 obstacles for computerized ECG interpretation: noisy waveform data, limited access to physician-validated digital 12-lead ECGs, no standardized diagnostic criteria and inadequate use of clinical context.
- The app workflow shown in the abstract figure has 4 steps: ECG digitization, interpretation and diagnostics, referral recommendations, and sharing and collaboration.
Published in: ISCE 2023 (International Society for Computerized Electrocardiology); abstract published in the Journal of Electrocardiology, Volume 78
Published on: 30 March 2023
Background
Worldwide, millions of ECGs are recorded every year, yet in many cases an expert cardiologist with sufficient training to evaluate the recording competently is not readily available, causing frequent misdiagnoses and discrepancies in patient management. Computerized interpretation of electrocardiograms was introduced to address this, but despite improvements over recent years, the simple algorithms built into ECG devices often provide inadequate interpretations. The main obstacles to better diagnostic performance are error-proneness with frequently encountered noisy waveform data, limited access to physician-validated 12-lead ECG data in digital format, the absence of standardized diagnostic criteria, and inadequate incorporation of clinical context.
Methods
The authors present PMcardio, a versatile smartphone application that uses image recognition and AI to standardize and digitize images of 12-lead ECGs. After digitization, the application interprets 38 different cardiovascular diseases and provides guideline-compliant recommendations for patient referral and for further diagnostic and treatment options.
Results
This abstract is a technology description and does not report a study cohort, diagnostic accuracy or outcome data. Its figure illustrates the app workflow in four steps: ECG digitization from a smartphone photograph, interpretation and diagnostics, referral recommendations, and sharing and collaboration between clinicians.
Conclusion
PMcardio combines smartphone-based digitization of 12-lead ECGs with AI interpretation of 38 cardiovascular diseases and guideline-compliant referral and treatment recommendations, aiming to address the misdiagnoses and inconsistent patient management that arise when an expert cardiologist is not readily available.
About PMcardio
PMcardio is the market leader in AI-powered diagnostics, addressing the world’s leading cause of death – cardiovascular diseases. The innovative clinical assistant empowers healthcare professionals to detect up to 40 cardiovascular diseases. In the form of a smartphone application, the certified Class IIb medical device interprets any 12-lead ECG image in under 5 seconds to provide accurate diagnoses and individualized treatment recommendations tailored to each patient.
About Powerful Medical
Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
Established in 2017, Powerful Medical has embarked on a mission to revolutionize the diagnosis and treatment of cardiovascular diseases. We are a medical company backed by 28 world-class cardiologists and led by our expert Scientific Board with decades of experience in daily patient care, clinical research, and medical devices. The results of our research are implemented, developed, certified, and brought to market by our 50+ strong interdisciplinary team of physicians, data scientists, AI experts, software engineers, regulatory specialists, and commercial teams.